Surface Modification of Spider Silk Particles to Direct Biomolecular Corona Formation.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
03 Jun 2020
Historique:
pubmed: 6 5 2020
medline: 16 2 2021
entrez: 6 5 2020
Statut: ppublish

Résumé

In recent years, spider silk-based materials have attracted attention because of their biocompatibility, processability, and biodegradability. For their potential use in biomaterial applications, i.e., as drug delivery systems and implant coatings for tissue regeneration, it is vital to understand the interactions between the silk biomaterial surface and the biological environment. Like most polymeric carrier systems, spider silk material surfaces can adsorb proteins when in contact with blood, resulting in the formation of a biomolecular corona. Here, we assessed the effect of surface net charge of materials made of recombinant spider silk on the biomolecular corona composition. In-depth proteomic analysis of the biomolecular corona revealed that positively charged spider silk materials surfaces interacted predominantly with fibrinogen-based proteins. This fibrinogen enrichment correlated with blood clotting observed for both positively charged spider silk films and particles. In contrast, negative surface charges prevented blood clotting. Genetic engineering allows the fine-tuning of surface properties of the spider silk particles providing a whole set of recombinant spider silk proteins with different charges or peptide tags to be used for, for example, drug delivery or cell docking, and several of these were analyzed concerning the composition of their biomolecular corona. Taken together this study demonstrates how the surface net charge of recombinant spider silk surfaces affects the composition of the biomolecular corona, which in turn affects macroscopic effects such as fibrin formation and blood clotting.

Identifiants

pubmed: 32369330
doi: 10.1021/acsami.0c06344
doi:

Substances chimiques

Protein Corona 0
Silk 0
Fibrinogen 9001-32-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24635-24643

Auteurs

Alessia C G Weiss (ACG)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and the Department of Chemical Engineering, The University of Melbourne, Victoria 3010, Australia.

Heike M Herold (HM)

Lehrstuhl für Biomaterialien, Universität Bayreuth, Prof. Rüdiger-Bormann-Strasse 1, Bayreuth 95447, Germany.

Sarah Lentz (S)

Lehrstuhl für Biomaterialien, Universität Bayreuth, Prof. Rüdiger-Bormann-Strasse 1, Bayreuth 95447, Germany.

Matthew Faria (M)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Parkville, Victoria 3052, Australia.
Systems Biology Laboratory, School of Mathematics and Statistics, and the Department of Biomedical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.

Quinn A Besford (QA)

Leibniz-Institute für Polymerforschung, Hohe Straβe 6, Dresden 01069 , Germany.

Ching-Seng Ang (CS)

Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.

Frank Caruso (F)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and the Department of Chemical Engineering, The University of Melbourne, Victoria 3010, Australia.

Thomas Scheibel (T)

Lehrstuhl für Biomaterialien, Universität Bayreuth, Prof. Rüdiger-Bormann-Strasse 1, Bayreuth 95447, Germany.
Bayreuther Zentrum für Kolloide und Grenzflächen (BZKG), Universität Bayreuth, Bayreuth 95440, Germany.
Bayreuther Zentrum für Molekulare Biowissenschaften (BZMB), Universität Bayreuth, Bayreuth 95440, Germany.
Bayreuther Materialzentrum (BayMAT), Universität Bayreuth, Bayreuth 95440, Germany.
Bayerisches Polymerinstitut (BPI), Universität Bayreuth, Bayreuth 95440, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH